Table 2.
Compound | Cell lines | ||||||
---|---|---|---|---|---|---|---|
A-549 | BGC-823 | HepG2 | HL-60 | MCF-7 | SMMC-7721 | W480 | |
1 | 10.3 | 11.3 | 9.2 | 12.0 | 10.7 | 23.7 | 28.0 |
2 | 52.7 | 61.8 | 49.0 | 59.4 | 54.3 | 59.7 | 59.5 |
3 | 44.1 | 40.8 | 30.4 | 39.6 | 36.8 | 47.0 | 40.1 |
4 | - | - | - | - | - | - | 94.9 |
5 | 97.4 | - | - | - | - | 92.1 | - |
6 | 13.0 | 12.9 | 10.8 | 12.3 | 11.3 | 24.9 | 29.9 |
7 | 49.1 | 53.2 | 43.6 | 48.2 | 46.7 | 49.4 | 52.7 |
8 | 47.8 | 51.5 | 44.8 | 50.7 | 48.9 | 53.2 | 51.4 |
9 | 61.3 | 67.1 | 58.3 | 71.8 | 64.2 | 66.2 | 62.1 |
10 | 16.1 | 15.7 | 14.8 | 17.2 | 14.7 | 31.2 | 35.5 |
Doxorubicin | 18.3 | 14.7 | 22.0 | 31.7 | 24.9 | 35.4 | 15.9 |
a Doxorubicin activities are expressed as IC50 values in nM, and those of compounds 1–8 are expressed as IC50 values in μM. (-) IC50 > 100 μM.